{"basic_info": {"ticker": "2821", "exchange": "XSHE", "bloomberg_ticker": "002821 CH Equity", "name": "ASYMCHEM LABORATORIES TIAN-A", "industry": "Pharmaceuticals", "name_chinese_simplified": "凯莱英", "period": "2020", "market_value": 70663929856, "total_income": 1265933056, "ccy": "人民币元", "shariah_compliance_summary": "compliant"}, "business_activity_screening": {"summary": [{"shariah_compliance": "compliant", "income": 1264058198, "business_income_over_total_income": 0.9985189911969563}, {"shariah_compliance": "unknown", "income": 1874857, "business_income_over_total_income": 0.0014810080131125037}], "details": [{"business_activity_cn": "临床阶段（定制研发生产）", "business_activity_en": "Clinical stage (customized R & D)", "income": 415897211, "business_income_over_total_income": 0.32853017703331067, "shariah_compliance": "compliant"}, {"business_activity_cn": "商业化阶段（定制研发生产）", "business_activity_en": "Commercialization stage (customized R & D)", "income": 736779387, "business_income_over_total_income": 0.5820050148054591, "shariah_compliance": "compliant"}, {"business_activity_cn": "技术服务", "business_activity_en": "Technical Services", "income": 111381600, "business_income_over_total_income": 0.08798379935818659, "shariah_compliance": "compliant"}, {"business_activity_cn": "其他业务收入", "business_activity_en": "Other operating income", "income": 1874857, "business_income_over_total_income": 0.0014810080131125037, "shariah_compliance": "unknown"}, {"business_activity_cn": "合计特别调整", "business_activity_en": "Total special adjustments", "income": 0, "business_income_over_total_income": 0.0, "shariah_compliance": "unknown"}]}, "financial_screening": [{"item": "Debt to Market Capitalization", "amount": 5.718118158991422e-05, "shariah_compliance": "compliant", "amount_over_market_value": 5.718118158991422e-05}]}